By: Tamara Yunusova, Senior Staff Editor – Proton Pump Inhibitors (PPIs) are acid-reducing agents that have multiple uses in the treatment and prophylaxis of conditions such as peptic ulcer diseases, H. Pylori infection, Zollinger-Ellison syndrome, GERD, and NSAID gastroduodenal ulcers. Their versatility in treating a wide range of conditions, unparalleled efficacy over their Histamine-2-receptor antagonist…

By: Davidta Brown, Staff Editor – Pathogenic bacteria have been enemies to human health for centuries. As recently as last month, the Centers for Disease Control published an 80-page document informing the public about America’s biggest microbial threats. Most of the pathogens on the list exhibit antibacterial resistance. One particular bacterial species, ranked at threat…

By: Beatrisa Popovitz, Staff Editor –  For the past decade, antibiotic resistant bacteria have been a growing concern in healthcare. Over the last few months, there has been a great deal of media attention surrounding strains of drug resistant bacteria in hospitals across the United States.  Most recently, there has been an increased effort to…

By: Lauren Kaveski, Pharm.D. Candidate c/o 2013 – We see proton pump inhibitors (PPIs) used in many medication regimens, but it is unknown whether the majority of patients receive these medications for appropriate durations or indications.  For all labeled indications, other than Zollinger-Ellison Syndrome (a rare condition characterized by damaging gastrin hypersecretion and subsequent hydrochloric…

By Ebey P. Soman – Many living organisms occupy our intestines to aid us with metabolism, recycling of hormones, and, most importantly, protection against foreign pathogens.  When this normal flora of bacteria is altered or eliminated via antibiotic use, there is an opportunity for Clostridium difficile to infect us.  Stool transplant, or fecal bacteriotherapy, is…